Stomorgyl 20 250 mg + 1 500 000 j.m Tabletka powlekana
Stomorgyl 20 250 mg + 1 500 000 j.m Tabletka powlekana
Authorised
- Metronidazole
- Spiramycin
Product identification
Medicine name:
Stomorgyl 20 250 mg + 1 500 000 j.m Tabletka powlekana
Active substance:
- Metronidazole
- Spiramycin
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Metronidazole250.00/milligram(s)1.00Tablet
-
Spiramycin1500000.00/international unit(s)1.00Tablet
Pharmaceutical form:
-
Film-coated tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01RA04
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Poland
Available in:
-
Poland
Package description:
- Available only in Polish
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
- Boehringer Ingelheim Animal Health France
Responsible authority:
- Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
- 1186
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Polish (PDF)
Published on: 20/05/2025
Labelling
This document does not exist in this language (English). You can find it
in another language below.
Polish (PDF)
Published on: 20/05/2025
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Polish (PDF)
Published on: 20/05/2025